CytomX Therapeutics, Inc. Transition Agreements
1 Contracts & Agreements
- Transition Agreement effective as of August 22, 2023 by and between CytomX Therapeutics, Inc., and AbbVie Global Enterprises Ltd (Filed With SEC on November 7, 2023)
